Voya Investment Management LLC lowered its position in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 10.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,198 shares of the technology company’s stock after selling 877 shares during the quarter. Voya Investment Management LLC’s holdings in Plexus were worth $922,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in PLXS. Fuller & Thaler Asset Management Inc. lifted its holdings in Plexus by 120.4% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock valued at $44,655,000 after purchasing an additional 190,360 shares in the last quarter. Nuveen LLC purchased a new position in Plexus during the first quarter valued at approximately $22,975,000. GAMMA Investing LLC lifted its holdings in Plexus by 19,069.1% during the first quarter. GAMMA Investing LLC now owns 170,797 shares of the technology company’s stock valued at $21,884,000 after purchasing an additional 169,906 shares in the last quarter. American Century Companies Inc. lifted its holdings in Plexus by 24.7% during the first quarter. American Century Companies Inc. now owns 678,222 shares of the technology company’s stock valued at $86,901,000 after purchasing an additional 134,205 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Plexus by 85.1% during the first quarter. Millennium Management LLC now owns 228,116 shares of the technology company’s stock valued at $29,229,000 after purchasing an additional 104,904 shares in the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Plexus Trading Down 1.1%
Shares of PLXS opened at $143.72 on Thursday. The company’s fifty day moving average is $134.21 and its 200 day moving average is $130.64. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $172.89. The stock has a market capitalization of $3.88 billion, a PE ratio of 24.48 and a beta of 0.82. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58.
Insider Buying and Selling
In related news, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $134.54, for a total value of $201,810.00. Following the sale, the chief executive officer owned 70,714 shares in the company, valued at approximately $9,513,861.56. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,500 shares of the business’s stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $137.71, for a total transaction of $344,275.00. Following the completion of the sale, the chief financial officer owned 20,959 shares in the company, valued at $2,886,263.89. This represents a 10.66% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 14,356 shares of company stock valued at $1,926,890 in the last three months. Corporate insiders own 1.76% of the company’s stock.
Wall Street Analyst Weigh In
PLXS has been the topic of several analyst reports. Needham & Company LLC lowered their price target on shares of Plexus from $162.00 to $158.00 and set a “buy” rating on the stock in a report on Thursday, July 24th. Williams Trading set a $165.00 price target on shares of Plexus in a report on Monday. Stifel Nicolaus set a $140.00 price target on shares of Plexus in a report on Thursday, July 24th. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $135.00 to $150.00 in a report on Friday, July 25th. Finally, Wall Street Zen downgraded shares of Plexus from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 16th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $155.60.
View Our Latest Analysis on Plexus
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- The 3 Best Blue-Chip Stocks to Buy Now
- Cybersecurity Market Set to Double: This ETF Offers Exposure
- Consumer Staples Stocks, Explained
- Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
- How to Invest in the FAANG Stocks
- Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.